<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Brisco MA</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>PHS HHS</funding><pagination>68-75</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4067252</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>The long-term durability and prognostic significance of improvement in renal function after mechanical circulatory support (MCS) has yet to be characterized in a large multicenter population. The primary goals of this analysis were to describe serial post-MCS changes in estimated glomerular filtration rate (eGFR) and determine their association with all-cause mortality.Adult patients enrolled in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) with serial creatinine levels available (n=3363) were studied. Early post-MCS, eGFR improved substantially (median improvement, 48.9%; P&lt;0.001) with 22.3% of the population improving their eGFR by ?100% within the first few weeks. However, in the majority of patients, this improvement was transient, and by 1 year, eGFR was only 6.7% above the pre-MCS value (P&lt;0.001). This pattern of early improvement followed by deterioration in eGFR was observed with both pulsatile and continuous-flow devices. Interestingly, poor survival was associated with both marked improvement (adjusted hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.19-2.26; P=0.002) and worsening in eGFR (adjusted HR, 1.63; 95% CI, 1.15-2.13; P=0.004).Post-MCS, early improvement in renal function is common but seems to be largely transient and not necessarily indicative of an improved prognosis. This pattern was observed with both pulsatile and continuous-flow devices. Additional research is necessary to better understand the mechanistic basis for these complex post-MCS changes in renal function and their associated survival disadvantage.URL: http://www.clinicaltrials.gov. Unique identifier: NCT00119834.</pubmed_abstract><journal>Circulation. Heart failure</journal><pubmed_title>Prevalence and prognostic importance of changes in renal function after mechanical circulatory support.</pubmed_title><pmcid>PMC4067252</pmcid><funding_grant_id>HHSN268201100025C</funding_grant_id><funding_grant_id>K23 HL114868</funding_grant_id><funding_grant_id>T32 HL007843</funding_grant_id><funding_grant_id>K24DK090203</funding_grant_id><funding_grant_id>1K23HL114868-02</funding_grant_id><funding_grant_id>5T32HL007843-15</funding_grant_id><funding_grant_id>K24 DK090203</funding_grant_id><funding_grant_id>5T32HL007891</funding_grant_id><funding_grant_id>T32 HL007891</funding_grant_id><pubmed_authors>Coca SG</pubmed_authors><pubmed_authors>Parikh CR</pubmed_authors><pubmed_authors>Brisco MA</pubmed_authors><pubmed_authors>Putt ME</pubmed_authors><pubmed_authors>Tang WW</pubmed_authors><pubmed_authors>Jessup M</pubmed_authors><pubmed_authors>Kimmel SE</pubmed_authors><pubmed_authors>Testani JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prevalence and prognostic importance of changes in renal function after mechanical circulatory support.</name><description>The long-term durability and prognostic significance of improvement in renal function after mechanical circulatory support (MCS) has yet to be characterized in a large multicenter population. The primary goals of this analysis were to describe serial post-MCS changes in estimated glomerular filtration rate (eGFR) and determine their association with all-cause mortality.Adult patients enrolled in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) with serial creatinine levels available (n=3363) were studied. Early post-MCS, eGFR improved substantially (median improvement, 48.9%; P&lt;0.001) with 22.3% of the population improving their eGFR by ?100% within the first few weeks. However, in the majority of patients, this improvement was transient, and by 1 year, eGFR was only 6.7% above the pre-MCS value (P&lt;0.001). This pattern of early improvement followed by deterioration in eGFR was observed with both pulsatile and continuous-flow devices. Interestingly, poor survival was associated with both marked improvement (adjusted hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.19-2.26; P=0.002) and worsening in eGFR (adjusted HR, 1.63; 95% CI, 1.15-2.13; P=0.004).Post-MCS, early improvement in renal function is common but seems to be largely transient and not necessarily indicative of an improved prognosis. This pattern was observed with both pulsatile and continuous-flow devices. Additional research is necessary to better understand the mechanistic basis for these complex post-MCS changes in renal function and their associated survival disadvantage.URL: http://www.clinicaltrials.gov. Unique identifier: NCT00119834.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jan</publication><modification>2020-10-29T14:02:12Z</modification><creation>2019-03-27T01:30:41Z</creation></dates><accession>S-EPMC4067252</accession><cross_references><pubmed>24214901</pubmed><doi>10.1161/circheartfailure.113.000507</doi><doi>10.1161/CIRCHEARTFAILURE.113.000507</doi></cross_references></HashMap>